MedPath

Survey of combination of Memantine and methylphenidate among treatment the children with ADHD(Attention-deficit/hyperactivity disorder)

Not Applicable
Conditions
Attention deficit hyperactivity disorder.
Disturbance of activity and attention
Registration Number
IRCT201208058317N2
Lead Sponsor
Research deputy of Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

1-Having diagnostic criteria based on the revised text of the fourth statistical detection guide to identify mental disorders and tests Conners (Test for diagnosing hyperactivity disorder and it’s grading), In this study, cases of moderate and severe impairment (score greater than or equal to 20 conners) are studied. 2-Age between 6 to 12 years. 3-Obtaining informed consent from parents. Exclusion criteria: 1-Other psychiatric disorder based on a criteria based DSM IV_TR 2-Mental retardation. 3-Having a history of seizures. 4-Any medical problems, including the use of beta blockers and methylphenidate such as asthma, cardiovascular problems, diabetes, history of allergy to drugs, the tic

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The amount of improvement of ADHD symptoms. Timepoint: Before the intervention, 1th, 2th, 3th and 4th weeks after intervention. Method of measurement: Conners test.
Secondary Outcome Measures
NameTimeMethod
Side effects. Timepoint: Before the intervention, 1th, 2th, 3th and 4th weeks after intervention. Method of measurement: Onset of symptoms based on parents day comment.
© Copyright 2025. All Rights Reserved by MedPath